Cite
HARVARD Citation
Yoo, D. et al. (n.d.). FRI0143 A randomized, double-blind, phase 3 study demonstrates clinical equivalence of CT-P13 to infliximab when co-administered with methotrexate in patients with active rheumatoid arthritis. Annals of the rheumatic diseases. p. 359. [Online].